ARCHIVES

NCI brings in grantees to explain their work, promise of nanotech, to advisory board.

This article is from The Cancer Letter archive.

Vol. 30 No. 29 | July 16, 2004

Download PDF Visit The Full Archive

Related Articles

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

Funding Opportunities.

May 10, 2002

In Brief: NCCS to hold Candlelight Vigil Sept. 25; Moffit Wins Chemistry-Biology Grants

September 17, 1999

Drugs and Targets: Akynzeo approved for chemotherapy-related nausea

October 10, 2014

Cooperative Group Problems, Solutions Analyzed By CTEP Staff

May 2, 1986

Some Children With Hodgkin’s Disease Can Reduce Or Skip Radiation, Study Finds

October 29, 2004